Kinetic patterns of single cell gene expression discriminate between the murine cellular responses to live attenuated and inactivated Yellow Fever vaccines

Budha Chatterjee,Christopher T. Boughter,Katrina Gorga,Yuko Ohta,Carly Blair,Elizabeth M. Hill,Zachary Fasana,Maxine Atuheirwe,Adedola Adebamowo,Farah Ammar,Natarajan Ayithan,JP Courneya,Ivan Kosik,Vel Murugan,Wilbur H. Chen,Marcela F. Pasetti,Martin Meier-Schellersheim,Nevil J. Singh

DOI: https://doi.org/10.1101/2024.11.26.625490

2024-12-03

Abstract:The success of the live attenuated Yellow Fever vaccine (YF17D) that elicits immunity lasting over thirty years has made it a widely used model to understand the generation of durable protection. We compare the early single-cell level transcriptional response in mice to YF17D and an adjuvanted-inactivated, but less effective version (InYF). Within the first week, we identify 70 kinetic patterns in 45 cellular clusters, majority of which discriminate between the two formulations, some in a tissue and sex-specific manner. Intriguingly, differential transcripts fall into two categories, one whose association with YF17D or InYF is maintained even when decoupled from their cell-type of expression and the other where such cell-plus-gene pairing is critical to maintain differential marker status. We demonstrate applications of this resource, by identifying B cells with varied interferon and antigen responsiveness in relation to each vaccine. This high-resolution dataset is amenable to further biomarker discovery and hypothesis generation.

Immunology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to distinguish the differences in the early immune responses of the yellow fever live - attenuated vaccine (YF17D) and the inactivated vaccine (InYF) in mice through the dynamic patterns of single - cell gene expression. Specifically, the study aims to: 1. **Compare the early transcriptomic responses of the two vaccines**: Through single - cell RNA sequencing (scRNA - seq), the researchers hope to reveal the differences in the early transcriptomic responses of different cell types in mice to these two vaccines within the first week after inoculation with YF17D and InYF. 2. **Identify key biomarkers**: Through high - resolution data analysis, the researchers hope to find key biomarkers that can distinguish the early responses of these two vaccines. These biomarkers may help predict the effectiveness of vaccines and provide references for future vaccine design. 3. **Explore the effects of gender and tissue specificity**: The study also pays special attention to the effects of gender and tissue specificity on vaccine responses to better understand how these factors affect the immune response. 4. **Use the "dirty mouse" model to improve experimental relevance**: In order to be closer to the actual situation of the human immune system, the researchers used mice pre - treated with virus infection and parasite infection (VIPEX protocol), thus avoiding the problem of the unactivated immune system in the traditional SPF mouse model. Through these methods, the researchers hope to deeply understand the key host response mechanisms leading to long - term immune protection and provide theoretical support for the development of more effective vaccines.

Kinetic patterns of single cell gene expression discriminate between the murine cellular responses to live attenuated and inactivated Yellow Fever vaccines

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial

Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models

Molecular Signature of Human Virus Specific Effector CD8+ T Cells (83.20)

Interferon-induced activation state of circulating dendritic cells and monocytes triggered by yellow fever vaccination correlates with early protective antibody responses

Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination

Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones

A Systematic, Unbiased Mapping of CD8+ and CD4+ T Cell Epitopes in Yellow Fever Vaccinees

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Current status and future prospects of yellow fever vaccines

Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort

Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients

Vaccination reshapes the virus-specific T cell repertoire in unexposed adults

Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination

Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults

Immune response induced by standard and fractional doses of 17DD yellow fever vaccine